Reversal of human cellular senescence: roles of the p53 and p16 pathways
Open accessThe DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.
Abstract
Telomere erosion and subsequent dysfunction limits the proliferation of normal human cells by a process termed replicative senescence. Replicative senescence is thought to suppress tumorigenesis by establishing an essentially irreversible growth arrest that requires activities of the p53 and pRB tumor suppressor proteins. We show that, depending on expression of the pRB regulator p16, replicative senescence is not necessarily irreversible. We used lentiviruses to express specific viral and cellular proteins in senescent human fibroblasts and mammary epithelial cells. Expression of telomerase did not reverse the senescence arrest. However, cells with low levels of p16 at senescence resumed robust growth upon p53 inactivation, and limited growth upon expression of oncogenic RAS. In contrast, cells with high levels of p16 at senescence failed to proliferate upon p53 inactivation or RAS expression, although they re-entered the cell cycle without growth after pRB inactivation. Our results indicate that the senescence response to telomere dysfunction is reversible and is maintained primarily by p53. However, p16 provides a dominant second barrier to the unlimited growth of human cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“p16, an inhibitor of CDK4 and CDK6, is also key in several types of senescence26; p21 is activated early on senescence entry and p16 is activated later, probably to maintain the senescence phenotype27”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, cells that express low p16 INK4a levels (e.g., SEN(REP) or SEN(XRA) HCA2) senesce in response to severe damage by activating the p53 pathway; when p53 is subsequently inactivated in these cells, they resume proliferation [ 62 ], but do not lose the SASP.”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This accumulation results in persistent activation of RB family proteins, inhibition of E2F transactivation, and consequent cell-cycle arrest, which, in time, cannot be reversed by subsequent inactivation of RB family proteins or p53 (Beause ´ jour et al., 2003).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Beausejour et al., 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In senescent cells, however, the CDK2 inhibitor p21 WAF1/Cip1 ( CDKN1A ) and CDK4/6 inhibitor p16 INK4A ( CDKN2A ) accumulate.”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Beausejour et al., 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cell cycle controlling proteins p16, p21, and p53, normally inhibit cell cycle progression and have been shown to be accumulated in senescent cells [49–51].”
From T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment (2013) · cites this paper as [51]
Experimental — accuracy not yet measured
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Self-citationExtension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
A Third-Generation Lentivirus Vector with a Conditional Packaging System
Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., & Naldini, L. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8463-8471.1998 · Cited by 3,341
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
Self-citationSwitching and Signaling at the Telomere
Blackburn, E. H. (2001) · Cell · doi:10.1016/s0092-8674(01)00492-5 · Cited by 2,107
Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells
Paddison, P. J., Caudy, A. A., Bernstein, E., Hannon, G. J., & Conklin, D. S. (2002) · Genes & Development · doi:10.1101/gad.981002 · Cited by 1,552
Cited by
Items 201–300 of 1,003
Glucose regulated protein 78: A critical link between tumor microenvironment and cancer hallmarks
Li, Z., & Li, Z. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.02.001 · Cited by 167
Chen, J., Huang, X., Halicka, D., Brodsky, S., Avram, A., Eskander, J., Bloomgarden, N. A., Darzynkiewicz, Z., & Goligorsky, M. S. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00364.2005 · Cited by 142
“The p53/p21 pathway has been generally accepted as the crucial controller of the replicative senescence program (8, 48, 74), even though there are reports that suggest an important role of the p16 pathway (2).”
BackgroundWhen dormancy fuels tumour relapse
Santos-de-Frutos, K., & Djouder, N. (2021) · Communications Biology · doi:10.1038/s42003-021-02257-0 · Cited by 165
Efeyan, A., Ortega-Molina, A., Velasco-Miguel, S., Herranz, D., Vassilev, L. T., & Serrano, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0200 · Cited by 140
Bristol, M. L., Di, X. M., Beckman, M. J., Wilson, E. N., Henderson, S. C., Maiti, A., Fan, Z., & Gewirtz, D. A. (2012) · Autophagy · doi:10.4161/auto.19313 · Cited by 155
Exhaustion of T lymphocytes in the tumor microenvironment: Significance and effective mechanisms
Gholami, M. D., Kardar, G. A., Saeedi, Y., Heidari, S., Garssen, J., & Falak, R. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.10.002 · Cited by 161
Li, M., You, L., Xue, J., & Lu, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00522 · Cited by 137
Schwarze, S. R., Fu, V. X., Desotelle, J. A., Kenowski, M. L., & Jarrard, D. F. (2005) · Neoplasia · doi:10.1593/neo.05250 · Cited by 139
Lozano-Torres, B., Estepa-Fernández, A., Rovira, M., Orzáez, M., Serrano, M., Martínez-Máñez, R., & Sancenón, F. (2019) · Nature Reviews Chemistry · doi:10.1038/s41570-019-0108-0 · Cited by 140
Krizhanovsky, V., Xue, W., Zender, L., Yon, M., Hernando, E., & Lowe, S. W. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.73.048 · Cited by 138
Self-citationGeroconversion: irreversible step to cellular senescence
Blagosklonny, M. V. (2014) · Cell Cycle · doi:10.4161/15384101.2014.985507 · Cited by 138
Elevated Local Senescence in Diabetic Wound Healing Is Linked to Pathological Repair via CXCR2
Wilkinson, H. N., Clowes, C., Banyard, K. L., Matteuci, P., Mace, K. A., & Hardman, M. J. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.01.005 · Cited by 135
Telomere dysfunction, genome instability and cancer
Cheung, A. (2008) · Frontiers in Bioscience · doi:10.2741/2825 · Cited by 139
Cold‐inducible RNA binding protein in cancer and inflammation
Lujan, D. A., Ochoa, J. L., & Hartley, R. S. (2018) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1462 · Cited by 165
Martin-Ruiz, C., Saretzki, G., Petrie, J., Ladhoff, J., Jeyapalan, J., Wei, W., Sedivy, J., & von Zglinicki, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311980200 · Cited by 135
CPEB regulation of human cellular senescence, energy metabolism, and p53 mRNA translation
Burns, D. M., & Richter, J. D. (2008) · Genes & Development · doi:10.1101/gad.1697808 · Cited by 134
Cellular senescence and cancer chemotherapy resistance
Gordon, R. R., & Nelson, P. S. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.01.002 · Cited by 134
Cancer and aging: the importance of telomeres in genome maintenance
Rodier, F., Kim, S.-H., Nijjar, T., Yaswen, P., & Campisi, J. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.012 · Cited by 132
“In either case, when present, p53 is crucial for mediating the cellular response to telomere dysfunction [9, 18, 109, 111, 116, 117] (Fig.”
BackgroundSelf-citationPremature aging in vitamin D receptor mutant mice
Keisala, T., Minasyan, A., Lou, Y., Zou, J., Kalueff, A. V., Pyykkö, I. V., & Tuohimaa, P. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.03.007 · Cited by 144
Tumor cell senescence response produces aggressive variants
Yang, L., Fang, J., & Chen, J. (2017) · Cell Death Discovery · doi:10.1038/cddiscovery.2017.49 · Cited by 131
Putting the brakes on the cell cycle: mechanisms of cellular growth arrest
Pack, L. R., Daigh, L. H., & Meyer, T. (2019) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2019.05.005 · Cited by 143
Targeting Cardiac Stem Cell Senescence to Treat Cardiac Aging and Disease
Cianflone, E., Torella, M., Biamonte, F., De Angelis, A., Urbanek, K., Costanzo, F. S., Rota, M., Ellison-Hughes, G. M., & Torella, D. (2020) · Cells · doi:10.3390/cells9061558 · Cited by 132
Epigenetic Regulation of Cellular Senescence
Crouch, J., Shvedova, M., Thanapaul, R. J. R. S., Botchkarev, V., & Roh, D. (2022) · Cells · doi:10.3390/cells11040672 · Cited by 126
The atypical E2F family member E2F7 couples the p53 and RB pathways during cellular senescence
Aksoy, O., Chicas, A., Zeng, T., Zhao, Z., McCurrach, M., Wang, X., & Lowe, S. W. (2012) · Genes & Development · doi:10.1101/gad.196238.112 · Cited by 130
Self-citationCellular Senescence Promotes Skin Carcinogenesis through p38MAPK and p44/42MAPK Signaling
Alimirah, F., Pulido, T., Valdovinos, A., Alptekin, S., Chang, E., Jones, E., Diaz, D. A., Flores, J., Velarde, M. C., Demaria, M., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0108 · Cited by 128
Self-citationTelomeric 8-oxo-guanine drives rapid premature senescence in the absence of telomere shortening
Barnes, R. P., de Rosa, M., Thosar, S. A., Detwiler, A. C., Roginskaya, V., Van Houten, B., Bruchez, M. P., Stewart-Ornstein, J., & Opresko, P. L. (2022) · Nature Structural & Molecular Biology · doi:10.1038/s41594-022-00790-y · Cited by 127
Role of hypoxia in cellular senescence
Gao, H., Nepovimová, E., Heger, Z., Valko, M., Wu, Q., Kuča, K., & Adam, V. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106841 · Cited by 146
Molecular signaling and genetic pathways of senescence: Its role in tumorigenesis and aging
Zhang, H. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20919 · Cited by 128
Role of telomeres and telomerase in genomic instability, senescence and cancer
Deng, Y., & Chang, S. S. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700673 · Cited by 154
The DNA Damage Signaling Pathway Connects Oncogenic Stress to Cellular Senescence
Mallette, F. A., & Ferbeyre, G. (2007) · Cell Cycle · doi:10.4161/cc.6.15.4516 · Cited by 125
FGF-2 suppresses cellular senescence of human mesenchymal stem cells by down-regulation of TGF-β2
Ito, T., Sawada, R., Fujiwara, Y., Seyama, Y., & Tsuchiya, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.067 · Cited by 124
Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation
Koppelstaetter, C., Schratzberger, G., Perco, P., Hofer, J., Mark, W., Öllinger, R., Oberbauer, R., Schwarz, C., Mitterbauer, C., Kainz, A., et al. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00398.x · Cited by 124
“Although telomere shortening has been observed under these circumstances as well, the activation of CDKN2A seems to act as the dominant factor to limit growth (Beausejour et al ., 2003).”
BackgroundSmall-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype
Wiley, C. D., Schaum, N., Alimirah, F., Lopez-Dominguez, J. A., Orjalo, A. V., Scott, G., Desprez, P.-Y., Benz, C., Davalos, A. R., & Campisi, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-20000-4 · Cited by 124
Self-citationSenescent Carcinoma-Associated Fibroblasts Upregulate IL8 to Enhance Prometastatic Phenotypes
Wang, T., Notta, F., Navab, R., Joseph, J., Ibrahimov, E., Xu, J., Zhu, C.-Q., Borgida, A., Gallinger, S., & Tsao, M.-S. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0192 · Cited by 123
“Cell lines, tissue, and mouse strains This study was approved by the Research Ethics Board of the UniversityHealthNetwork (13-6377).”
BackgroundMethodAttenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence
Kolesnichenko, M., Hong, L., Liao, R., Vogt, P. K., & Sun, P. (2012) · Cell Cycle · doi:10.4161/cc.20683 · Cited by 123
Cellular senescence and cardiovascular diseases: moving to the “heart” of the problem
Evangelou, K., Vasileiou, P. V. S., Papaspyropoulos, A., Hazapis, O. G., Petty, R., Demaria, M., & Gorgoulis, V. G. (2022) · Physiological Reviews · doi:10.1152/physrev.00007.2022 · Cited by 136
Salmiņa, K., Jankevics, E., Huna, A., Perminov, D., Radoviča-Spalviņa, I., Klymenko, T., Ivanov, A., Jascenko, E., Scherthan, H., Cragg, M. S., et al. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.04.030 · Cited by 133
DNA Methylation Patterns Separate Senescence from Transformation Potential and Indicate Cancer Risk
Xie, W., Kagiampakis, I., Pan, L., Zhang, Y. W., Murphy, L., Tao, Y., Kong, X., Kang, B., Xia, L., Carvalho, F. L. F., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.008 · Cited by 122
Romanov, V. S., Pospelov, V. A., & Pospelova, T. V. (2012) · Biochemistry (Moscow) · doi:10.1134/s000629791206003x · Cited by 123
Cellular senescence in lung cancer: Molecular mechanisms and therapeutic interventions
Jha, S. K., Rubis, G. D., Devkota, S. R., Zhang, Y., Adhikari, R., Jha, L. A., Bhattacharya, K., Mehndiratta, S., Gupta, G., Singh, S. K., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102315 · Cited by 151
A human tRNA methyltransferase 9‐like protein prevents tumour growth by regulating LIN9 and HIF1‐α
Begley, U., Sosa, M. S., Avivar‐Valderas, A., Patil, A., Endres, L., Estrada, Y. D., Chan, C. T. Y., Su, D., Dedon, P. C., Aguirre‐Ghiso, J. A., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201161 · Cited by 134
ING2 Regulates the Onset of Replicative Senescence by Induction of p300-Dependent p53 Acetylation
Pedeux, R., Sengupta, S., Shen, J. C., Demidov, O. N., Saito, S., Onogi, H., Kumamoto, K., Wincovitch, S., Garfield, S. H., McMenamin, M., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6639-6648.2005 · Cited by 122
Deterioration of nuclear morphology and architecture: A hallmark of senescence and aging
Pathak, R. U., Soujanya, M., & Mishra, R. K. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101264 · Cited by 121
p53 and the Carcinogenicity of Chronic Inflammation
Gudkov, A. V., & Komarova, E. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026161 · Cited by 133
Roles and mechanisms of cellular senescence in regulation of tissue homeostasis
Ohtani, N., & Hara, E. (2013) · Cancer Science · doi:10.1111/cas.12118 · Cited by 119
SCFFbxo22-KDM4A targets methylated p53 for degradation and regulates senescence
Johmura, Y., Sun, J., Kitagawa, K., Nakanishi, K., Kuno, T., Naiki-Ito, A., Sawada, Y., Miyamoto, T., Okabe, A., Aburatani, H., et al. (2016) · Nature Communications · doi:10.1038/ncomms10574 · Cited by 118
Mechanisms and significance of therapy-induced and spontaneous senescence of cancer cells
Mikuła-Pietrasik, J., Niklas, A., Uruski, P., Tykarski, A., & Książek, K. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03261-8 · Cited by 119
Cellular senescence: Neither irreversible nor reversible
Reimann, M., Lee, S., & Schmitt, C. A. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20232136 · Cited by 136
Cellular senescence in cancer treatment: friend or foe?
Kahlem, P., Dörken, B., & Schmitt, C. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420784 · Cited by 119
Cell fate determination during G1 phase progression
Blomen, V. A., & Boonstra, J. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7271-z · Cited by 147
A common signature of cellular senescence; does it exist?
Sikora, E., Bielak-Żmijewska, A., & Mosieniak, G. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101458 · Cited by 135
Microenvironments Dictating Tumor Cell Dormancy
Bragado, P., Sosa, M. S., Keely, P. J., Condeelis, J. S., & Aguirre‐Ghiso, J. A. (2012) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-28160-0_3 · Cited by 126
Oncogene-induced senescence: From biology to therapy
Zhu, H., Blake, S., Kusuma, F. K., Pearson, R. B., Kang, J., & Chan, K. T. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111229 · Cited by 116
The Paradoxical Role of Cellular Senescence in Cancer
Yang, J., Liu, M., Hong, D., Zeng, M., & Zhang, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.722205 · Cited by 114
Cell Senescence: A Challenge in Cartilage Engineering and Regeneration
Li, J., & Pei, M. (2012) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2011.0583 · Cited by 114
He, Y., Li, W., Lv, D., Zhang, X., Zhang, X., Ortiz, Y. T., Budamagunta, V., Campisi, J., Zheng, G., & Zhou, D. (2020) · Aging Cell · doi:10.1111/acel.13117 · Cited by 114
Self-citationLiu, X., Hoft, D. F., & Peng, G. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133679 · Cited by 127
Cellular senescence: Its role in tumor suppression and aging
Ohtani, N., Mann, D. J., & Hara, E. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01123.x · Cited by 114
Genotoxic therapy and resistance mechanism in gliomas
Lang, F., Liu, Y., Chou, F.-J., & Yang, C. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107922 · Cited by 121
Tsuchiya, N., Izumiya, M., Ogata-Kawata, H., Okamoto, K., Fujiwara, Y., Nakai, M., Okabe, A., Schetter, A. J., Bowman, E. D., Midorikawa, Y., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2475 · Cited by 112
Premature senescence of endothelial cells: Methusaleh's dilemma
Chen, J., & Goligorsky, M. S. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01103.2005 · Cited by 111
Nagai, K., Matsushita, T., Matsuzaki, T., Takayama, K., Matsumoto, T., Kuroda, R., & Kurosaka, M. (2015) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2015.03.024 · Cited by 116
Mechanisms of obesity-induced metabolic and vascular dysfunctions
Caldwell, R. W. (2019) · Frontiers in bioscience · doi:10.2741/4758 · Cited by 122
Effects of Donor Age and Cell Senescence on Kidney Allograft Survival
Melk, A., Schmidt, B. M. W., Braunc, H., Vongwiwatana, A., Urmson, J., Zhu, L.-F., Rayner, D., & Halloran, P. F. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02500.x · Cited by 109
To clear, or not to clear (senescent cells)? That is the question
Lujambio, A. (2016) · BioEssays · doi:10.1002/bies.201670910 · Cited by 108
MicroRegulators come of age in senescence
Gorospe, M., & Abdelmohsen, K. (2011) · Trends in Genetics · doi:10.1016/j.tig.2011.03.005 · Cited by 108
van Wijnen, A. J., Bagheri, L., Badreldin, A. A., Larson, A. N., Dudakovic, A., Thaler, R., Paradise, C. R., & Wu, Z. (2020) · Bone · doi:10.1016/j.bone.2020.115659 · Cited by 117
Cellular senescence in pretransplant renal biopsies predicts postoperative organ function
McGlynn, L. M., Stevenson, K., Lamb, K., Zino, S., Brown, M., Prina, A., Kingsmore, D., & Shiels, P. G. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2008.00447.x · Cited by 108
Life or Death after a Break: What Determines the Choice?
Krenning, L., van den Berg, J., & Medema, R. H. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.08.023 · Cited by 118
How good is the evidence that cellular senescence causes skin ageing?
Low, E., Alimohammadiha, G., Smith, L. A., Costello, L. F., Przyborski, S. A., von Zglinicki, T., & Miwa, S. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101456 · Cited by 106
Skin-Aging Pigmentation: Who Is the Real Enemy?
Kim, J. C., Park, T. J., & Kang, H. Y. (2022) · Cells · doi:10.3390/cells11162541 · Cited by 135
Telomeres in aging and disease: lessons from zebrafish
Carneiro, M. C., de Castro, I. P., & Ferreira, M. G. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.025130 · Cited by 106
de Magalhães, J. P. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.07.006 · Cited by 121
Perwez Hussain, S., & Harris, C. C. (2006) · Journal of Nippon Medical School · doi:10.1272/jnms.73.54 · Cited by 107
Busulfan-induced senescence is dependent on ROS production upstream of the MAPK pathway
Probin, V., Wang, Y., & Zhou, D. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.020 · Cited by 105
“These findings are in agreement with the suggestion that p21 plays an important role in the initiation of senescence, while p16 is required for the maintenance of senescence [28].”
ResultThe PKB/FOXO switch in aging and cancer
Kloet, D. E. A., & Burgering, B. M. T. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.04.003 · Cited by 111
Targeting prostate cancer based on signal transduction and cell cycle pathways
Lee, J. T., Lehmann, B. D., Terrian, D. M., Chappell, W. H., Stivala, F., Libra, M., Martelli, A. M., Steelman, L. S., & McCubrey, J. A. (2008) · Cell Cycle · doi:10.4161/cc.7.12.6166 · Cited by 118
Thaler, S., Hähnel, P. S., Schad, A., Dammann, R., & Schüler, M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1377 · Cited by 113
Cellular senescence and radiation-induced pulmonary fibrosis
He, Y., Thummuri, D., Zheng, G., Okunieff, P., Citrin, D. E., Vujaskovic, Z., & Zhou, D. (2019) · Translational Research · doi:10.1016/j.trsl.2019.03.006 · Cited by 103
Pienta, K. J., Hammarlund, E. U., Brown, J. S., Amend, S. R., & Axelrod, R. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020838118 · Cited by 105
The effect of paclitaxel on apoptosis, autophagy and mitotic catastrophe in AGS cells
Khing, T. M., Choi, W. S., Kim, D., Po, W. W., Thein, W., Shin, C. Y., & Sohn, U. D. (2021) · Scientific Reports · doi:10.1038/s41598-021-02503-9 · Cited by 113
A Quiescent Bcl11b High Stem Cell Population Is Required for Maintenance of the Mammary Gland
Cai, S., Kalisky, T., Sahoo, D., Dalerba, P. D., Feng, W., Lin, Y., Qian, D., Kong, A., Yu, J. J., Wang, F., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.11.007 · Cited by 114
Targeting Senescent Cells in Fibrosis: Pathology, Paradox, and Practical Considerations
Schafer, M. J., Haak, A. J., Tschumperlin, D. J., & LeBrasseur, N. K. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0712-x · Cited by 110
Reversal of Hepatocyte Senescence After Continuous In Vivo Cell Proliferation
Wang, M.-J., Chen, F., Li, J.-X., Liu, C.-C., Zhang, H.-B., Xia, Y., Yu, B., You, P., Xiang, D., Lu, L., et al. (2014) · Hepatology · doi:10.1002/hep.27094 · Cited by 102
Bonventre, J. V. (2014) · Kidney International Supplements · doi:10.1038/kisup.2014.8 · Cited by 110
Regulation of lipids is central to replicative senescence
Lizardo, D. Y., Lin, Y.-L., Gokcumen, O., & Atilla-Gokcumen, G. E. (2017) · Molecular BioSystems · doi:10.1039/c6mb00842a · Cited by 102
Chemotherapy-induced senescence, an adaptive mechanism driving resistance and tumor heterogeneity
Guillon, J., Petit, C., Toutain, B., Guette, C., Lelièvre, E., & Coqueret, O. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1652047 · Cited by 102
“[24] Beausejour CM, Krtolica A, Galimi F, et al.”
BackgroundConserved senescence associated genes and pathways in primary human fibroblasts detected by RNA-seq
Marthandan, S., Baumgart, M., Priebe, S., Groth, M., Schaer, J., Kaether, C., Guthke, R., Cellerino, A., Platzer, M., Diekmann, S., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154531 · Cited by 91
“However, the strong up-regulation of p16 during replicative senescence in BJ fibroblasts observed here, does not agree with previous studies [95, 96].”
ResultCellular senescence and tumor promotion: Is aging the key?
Loaiza, N., & Demaria, M. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.01.007 · Cited by 101
The clinical impact and biological mechanisms of skeletal muscle aging
Aversa, Z., Zhang, X., Fielding, R. A., Lanza, I., & LeBrasseur, N. K. (2019) · Bone · doi:10.1016/j.bone.2019.05.021 · Cited by 101
Li, P., Gan, Y., Xu, Y., Song, L., Wang, L., Ouyang, B., Zhang, C., & Zhou, Q. (2017) · Scientific Reports · doi:10.1038/srep42938 · Cited by 117
Zhang, X., Liu, X., Du, Z., Wei, L., Fang, H., Dong, Q., Niu, J., Li, Y., Gao, J., Zhang, M. Q., et al. (2021) · Genome Research · doi:10.1101/gr.275235.121 · Cited by 99
Li, Z., Jiang, K., Zhu, X., Lin, G., Song, F., Zhao, Y., Piao, Y., Liu, J., Cheng, W., Bi, X., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.11.015 · Cited by 107
Impaired Myofibroblast Dedifferentiation Contributes to Nonresolving Fibrosis in Aging
Kato, K., Logsdon, N. J., Shin, Y.-J., Palumbo, S., Knox, A., Irish, J. D., Rounseville, S. P., Rummel, S. R., Mohamed, M., Ahmad, K., et al. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0092oc · Cited by 114
Golde, T. E., & Miller, V. M. (2009) · Alzheimer's Research & Therapy · doi:10.1186/alzrt5 · Cited by 98
Kirschner, K., Chandra, T., Kiselev, V., Flores-Santa Cruz, D., Macaulay, I. C., Park, H. J., Li, J., Kent, D. G., Kumar, R., Pask, D. C., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.074 · Cited by 100
Jin-hong, X., Shi, F., Deng, S., Li, H., Lin, X., Huang, Y., Chung, S., Shu, Y., & Shao, Z. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00963-6 · Cited by 109
Tumour resistance in induced pluripotent stem cells derived from naked mole-rats
Miyawaki, S., Kawamura, Y., Oiwa, Y., Shimizu, A., Hachiya, T., Bono, H., Koya, I., Okada, Y., Kimura, T., Tsuchiya, Y., et al. (2016) · Nature Communications · doi:10.1038/ncomms11471 · Cited by 95
Self-citationIRF3 activates RB to authorize cGAS-STING–induced senescence and mitigate liver fibrosis
Wu, Q., Leng, X., Zhang, Q., Zhu, Y., Zhou, R., Liu, Y., Chen, M., Zhang, D., Liu, S., Chen, S., et al. (2024) · Science Advances · doi:10.1126/sciadv.adj2102 · Cited by 115
Houck, A. L., Seddighi, S., & Driver, J. A. (2019) · Current Aging Science · doi:10.2174/1874609811666180223154436 · Cited by 95
Metadata
- Authors
- Beauséjour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., & Campisi, J.
- Affiliations
- Lawrence Berkeley National Laboratory (US)
- Salk Institute for Biological Studies (US)
- Cold Spring Harbor Laboratory (US)
- Buck Institute for Research on Aging (US)
- Corresponding author
- Campisi, Judith
- Venue
- The EMBO Journal
- Published
- 2003-08-15
- Volume
- 22
- Issue
- 16
- Pages
- 4212-4222
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC175806
- OpenAlex
- W2061619522
- Cited by
- 1,457
- References
- 61
- Citations by year
- 2026: 46 · 2025: 58 · 2024: 87 · 2023: 94 · 2022: 77 · 2021: 107 · 2020: 77 · 2019: 77 · 2018: 78 · 2017: 63 · 2016: 74 · 2015: 55 · 2014: 59 · 2013: 54 · 2012: 69
- FWCI
- 21.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- The EMBO Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- UnissResearch (Università degli Studi di Sassari) (submittedVersion)
- Funders
- Uehara Memorial Foundation
- National Institute on Aging (R56AG009909, R56AG016379, AG-09909, AG-16379, R01AG016379, R37AG009909)
- National Cancer Institute (P30CA008748)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, replicative senescence, p53, p16, retinoblastoma protein, telomere dysfunction, telomerase, oncogenic Ras, growth arrest, senescence reversal, mammary epithelial cells, fibroblasts, tumor suppression
- MeSH terms
- Breast, Cell Line, Epithelial Cells, Fibroblasts, Humans, Luminescent Proteins, Models, Biological, Genes, ras, Signal Transduction, Tumor Suppressor Protein p53, Lentivirus Infections, Cellular Senescence, Telomerase, Cyclin-Dependent Kinase Inhibitor p16, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.